Investing Upstream: How Treating Adult ADHD Could Mitigate the Approaching Dementia Crisis in the UK
The UK faces a projected surge in dementia prevalence while an estimated 2.5 million adults live with undiagnosed ADHD. Recent longitudinal evidence establishes untreated adult ADHD as a significant modifiable risk factor for dementia, and suggests treatment may neutralise the elevated risk. This paper argues that closing the ADHD treatment gap is a critical, cost-effective strategy for dementia prevention.
Read the paper